July 27, 2011


Valeritas V-Go Disposable Insulin Delivery Device Gets European Approval

Having received FDA approval last December, Valeritas of Bridgewater, NJ has followed up with the European CE Mark for its V-Go disposable basal-bolus insulin delivery device. It provides a continuous baseline of insulin as well as on-demand bolus doses.

The microneedle device, that does not contain any electronics, works for 24 hours and is then thrown away.  It is available in basal rates of 20, 30 or 40 Units of insulin and feature two bolus doses.

More about the V-Go from Valeritas:

The V-Go is engineered to simplify basal-bolus insulin therapy for the millions of people suffering from Type 2 diabetes. The V-Go is small, lightweight, and worn under the patients’ clothing. It measures just 2.4 x 1.3 x 0.5 inches and weighs approximately 1 ounce when filled with insulin. Patients apply a new V-Go to the skin daily for one 24-hour period. The V-Go is not electronic, making it easy to operate and use.

The V-Go is filled with insulin using a very simple point-of-care filling accessory — the EZ Fill (which will be included with each monthly supply of V-Go devices). A separate prescription for insulin is required for use with the V-Go. Humalog® and NovoLog® have both been tested by Valeritas, Inc. and found safe for use with the V-Go Disposable Insulin Delivery Device.